The tat gene of the human immunodeficiency virus, tat-III, when introduced into T-lymphoblastoid Jurkat cells by a Moloney retroviral recombinant DNA vector expressed high levels of the functional tat protein as measured by the chloramphenicol acetyltransferase assay. Immunofluorescence analysis with CD4-specific monoclonal antibodies demonstrated that the cell surface levels of the CD4 antigen were increased by 5-to 10-fold in the tat-III-infected Jurkat cells. Cellular cytoplasmic RNA analysis indicated that the enhanced CD4 expression was mediated at the mRNA level. Our findings suggest that the single expression of the human immunodeficiency virus tat protein in the absence of the other viral proteins causes an upregulation of CD4 gene expression on helper T cells, although infection of these cells by the virus, thus expressing all the viral gene products including tat, is known to downregulate CD4 antigen expression.
The tat gene of the human immunodeficiency virus, tat-III, when introduced into T-lymphoblastoid Jurkat cells by a Moloney retroviral recombinant DNA vector expressed high levels of the functional tat protein as measured by the chloramphenicol acetyltransferase assay. Immunofluorescence analysis with CD4-specific monoclonal antibodies demonstrated that the cell surface levels of the CD4 antigen were increased by 5-to 10-fold in the tat-III-infected Jurkat cells. Cellular cytoplasmic RNA analysis indicated that the enhanced CD4 expression was mediated at the mRNA level. Our findings suggest that the single expression of the human immunodeficiency virus tat protein in the absence of the other viral proteins causes an upregulation of CD4 gene expression on helper T cells, although infection of these cells by the virus, thus expressing all the viral gene products including tat, is known to downregulate CD4 antigen expression.
The human immunodeficiency virus (HIV), which is tissue-tropic for CD4+ cells, binds to the CD4A and some other epitopes of the CD4 antigen (10, 11, 20, 28, 37) . CD4A-like epitopes expressed on different cells, including non-T cells and cells transfected with the CD4 gene, can also serve as receptors for HIV but with altered binding affinity (10, 20, 28) . Following the binding of HIV to the CD4 molecules, the virus is internalized by receptor-mediated endocytosis (16) . Infection of CD4+ cells with HIV produces a complex between the virus-encoded 110,000-molecular-weight env glycoprotein and the CD4 antigen (19) . Surface expression of these two proteins on the HIV-infected cells is thought to promote the formation of syncytia or giant cells, leading to decreased numbers of CD4 molecules and CD4+ cells and the ultimate loss or destruction of the latter (14, 20, 29) . It was found recently, however, that syncytium formation is not the primary cause for the cytopathic effects of HIV (31) . Monoclonal antibodies directed against certain epitopes of the CD4 antigen prevent HIV binding, infection, and cell fusion (19, 28) . Although such fusion events reduce the number of available CD4 molecules on the cell surface, other regulatory factors, such as the virus-encoded tat gene product, could potentially alter the expression of host genes including CD4. The tat-III gene product has been shown to regulate viral gene expression at the transcriptional or posttranscriptional level via the viral long terminal repeat (LTR), resulting in increased mRNA and protein synthesis, respectively (3, 4, 6, 23, 25, 26, 30) .
The CD4 antigen, which is a surface marker of the T-lymphocyte helper cells, is involved in the recognition of major histocompatibility complex (MHC) class II antigens in conjunction with the Ti-CD3 complex and a foreign antigen such as a virus (5, 34) . Although infection of CD4+ cells with HIV ultimately leads to their destruction, the viral genes responsible for all the changes which lead to the pathogenesis of HIV are not clear (13) . One difficulty inherent in the study of virus-induced changes in host gene expression is the loss of cells under investigation owing to the cytopathic effects of the virus (13, 37) . Therefore, a study of such virus-controlled regulation of host gene expression leading to pathogenesis of HIV might best be accomplished by a study of the effect of the individual viral genes. We investigated the effect produced by the tat gene on the expression of CD4 antigen on T-lymphoblastoid Jurkat cells in the absence of expression of the other viral genes. Any significant modulation in the levels of the virus receptor CD4 molecule could potentially affect virus binding to the helper T cells. We found that the tat-III gene product increases the CD4 antigen levels by 5-to 10-fold and increases CD4 mRNA levels.
The cells were maintained in RPMI 1640 medium containing 10% fetal calf serum, 1% penicillin-streptomycin, and 1% ment of the T-cell-receptor gene was isolated by digestion with HinclI and BglII (1) . The cDNA fragments were isolated after agarose gel electrophoresis by electroelution with an electroelutor (model UEA; International Biotechnologies, Inc., New Haven, Conn.) or by using low-meltingpoint agarose. The cDNA fragments were labeled with 32P as described previously (7, 8) . The 32P-labeled cDNA samples (100 plI) were spin dialyzed on 1.5 ml of Sepharose CL-6B
(Pharmacia, Inc., Piscataway, N.Y.) at 3,000 x g for 3 min for the removal of the unincorporated deoxynucleotide triphosphates. Cellular DNA was isolated by standard procedures (18) . The purified DNA samples (20 ,ug) were digested with the appropriate restriction enzyme and run on 0.7% agarose gels at 35 V for 18 h. The gels were UV irradiated for 10 min, denatured in 0.2 N NaOH, and neutralized in a Tris buffer and EDTA. Southern transfer and hybridization were done with a Gene Screen Plus filter (Dupont, NEN Research Products, Boston, Mass.) under conditions suggested by the manufacturer.
The Jurkat cell clones used in our study were all derived from the same parental cell lineage, as shown by DNA restriction fragment length polymorphism analysis. The genomic DNAs were digested with PvuII or HindIll and hybridized with 32P-labeled HLA-B7 cDNA (12, 32) or the HLA-DR, cDNA (35) probe. A positive-control DNA sample from a Jurkat AW subclone (36) was also used for comparison with the restriction fragment length polymorphisms of infected and uninfected Jurkat cells. The genomic blots of these cellular DNA samples showed identical restriction patterns within the MHC class I and class II genes between the uninfected and infected Jurkat clones (data not shown). As expected, however, the negative-control genomic DNAs from the human T-lymphoid line HUT78 and the B lymphoid line Raji showed restriction fragment length polymorphism patterns different from those of Jurkat cells. The same cellular DNA samples were also digested with EcoRI or HindIII and hybridized with the C1 fragment of the T-cell-receptor cDNA clone (p,BREX) (1) . Again, no polymorphisms or clonal differences could be found to account for the significant increases in CD4 gene expression observed in the tat-III-expressing clones (data not shown).
The cloned neomycin-resistant Jurkat cells were assayed for expression of the tat-III gene by the chloramphenicol acetyltransferase (CAT) assay (15) . The uninfected, tat-IIIinfected, and control antisense-tat-II-infected Jurkat cells were transfected by the DEAE-dextran procedure (15) . The cells (5 x 106) were incubated in 1.5 ml of RPMI 1640 medium containing DEAE-dextran (50 ,ug/ml) and the pL3CATc plasmid ( (Table 1 ). All the enzyme assays were performed in the same manner by incubation at 37°C for 2 h with 0.6 mg of cellular protein contained in each CAT assay reaction. Thin-layer chromatography was performed on all the reaction products at the same time, and Kodak X-ray films were exposed to 14C from the thin-layer chromatography plates for the same duration. The results were normalized to a control parallel transfection with a plasmid, pSV2CAT, containing the simian virus 40 promoter-enhancer (27) . The pL3CATc and pSV2CAT plasmids were from G. N. Pavlakis (Frederick Cancer Research Facility, National Cancer Institute) and N. Rosenthal (Harvard Medical School), respectively. The simian virus 40-driven CAT levels, which apparently are low for the tat-III-infected Jurkat clones (Table 1) , are not due to differences in experimental conditions. We believe this is possibly due to a negative regulatory effect by the tat protein on the simian virus 40 transcriptional regulatory elements. This interesting and consistent effect is under investigation.
Monoclonal antibodies specific for the CD4 and CD4A epitopes of the CD4 antigen (OKT4 and OKT4A, respectively [Ortho Diagnostics, Inc., Raritan, N.J.]) were used for immunofluorescence analysis. For the two-color direct immunofluorescence analysis, the red fluorescence phycoerythfin-labeled OKT4 and the green fluorescence fluorescein isothiocyanate-labeled OKT4A monoclonal antibodies (both from Ortho Diagnostics) and the CD3 antigen-specific antiLeu-4-fluorescein isothiocyanate (Becton Dickinson and Co., Paramus, N.J.) monoclonal antibody were used. A Jurkat cell clonotypic REX monoclonal antibody which was used for assay of the T-cell-receptor antigen levels was from 0. Acuto (24) were resistant to G418. All three tat-Ill-positive clones that were tested for binding of the CD4 antigen-specific monoclonal antibodies showed 5-to 10-fold increases in the levels of expression of the CD4 antigen when compared with the uninfected or control-infected Jurkat cells either by indirect immunofluorescence analysis (data not shown) or by a two-color fluorescence analysis by direct binding of the labeled monoclonal antibodies (Table 2) . Comparable results were also obtained for clone B (data not shown). These cells did not suggest any epitope-specific intramolecular alterations in the binding of the CD4 and CD4A epitope-specific monoclonal antibodies (Table 2) . Both antibodies showed concomitant increases in their binding levels to the tat-III-infected clones.
Total cellular RNA was extracted from the uninfected and infected cells by the guanidiniurm isothiocyanate-CsCl ultracentrifugation procedure (18 The filters were prehybridized overnight at 42°C in a solution containing 5 x SSC, 1% sodium dodecyl sulfate, 5 x Denhardt solution, 100 ,ug of single-stranded DNA per ml, and 50% formamide. Hybridization mixtures with the labeled cDNA contained 10% dextran T-500 in prehybridization solution and the 32P-labeled probe at 5 x 106 cpm per lane, and hybridization was performed at 42°C for 18 h. The filters were then washed sequentially in 2 x SSC-0. 1% sodium dodecyl sulfate and in 0.2x SSC-0.1% sodium dodecyl sulfate at room temperature and 42°C, respectively. The dot blots of CD4-and actin mRNA-containing filters were also performed with nitrocellulose filters, using a Bio-Rad apparatus. Filters were hybridized with 32P-labeled probe at 42°C and treated as for Northern (RNA) blots. The dot blots were quantitated with an LKB scanning densitometer. All the RNA samples were analyzed at the same time, and the X-ray films were exposed for the same duration (48 h). The dot blot shown in Fig. 1B is of the same membrane.
The observed increases in the levels of the CD4 antigen in the tat-III-infected cells were secondary to increased levels of the 3.0-kilobase CD4 transcript (16) as seen in the total cellular RNA blot analysis (Fig. 1) . Data on clone C was comparable but was not included (Fig. 1A) . Densitometric scanning or scintillation counting quantitation showed that the CD4 mRNA levels in all three tat-III-infected clones were increased by factors of 8-to 10-fold relative to those in uninfected or control (antisense-tat-If) infected cells, while the actin mRNA levels remained unchanged. The five control-infected (anti-tat-II) Jurkat clones did not exhibit increases in the levels of CD4 antigen or CD4 mRNA, thus suggesting that the increased CD4 gene expression was mediated by the tat-III protein.
An incidental finding of this study was that the levels of expression of the clonotypic T-cell receptor (Ti)-CD3 anti- gen complex were also increased in the tat-infected cells independent of tat expression. Control experiments indicate that this was due to the retrovirus vector that was used for the introduction of the tat-IllI DNA or the antisense-tat-II DNA into the Jurkat cells (data not shown).
HIV infection of CD4+ T lymphocytes (via the CD4 antigen) leads to a substantial reduction in the numbers of these antigens on the cells (13) . HIV infection of CD4+ T cells, including Jurkat cells, caused a downregulation of the levels of CD4 antigen and its mRNA (9) . We report here that the expression of the viral tat gene alone in the CD4+ Jurkat cells and in the absence of expression of the other viral proteins caused increased levels of expression of the CD4 antigen and its mRNA. The mechanisms by which the HIV tat gene product increases the level of certain cellular proteins remain incompletely understood. The tat gene of HIV was previously found to increase the expression of certain HIV genes in these same Jurkat cells, via the viral LTR, by a disproportionately greater increase in viral protein synthesis relative to mRNA synthesis (25) . Others have reported that the HIV tat gene acts predominantly at the level of transcriptional accumulation of mRNA from a CAT gene driven by the HIV LTR in vitro (21) . It was also reported that an inducible cellular nuclear transcription factor in these same tat-III-infected Jurkat cells could act synergistically with the tat protein on the HIV LTR to promote additional transcription (22) . Our results suggest that the increased CD4 antigen expression on these Jurkat cells which was mediated by the tat protein is due to a comparable increase in the level of the CD4 mRNA.
The interesting discrepancy between the reported suppression of CD4 gene expression by infection with the whole HIV and our observed enhancement of CD4 antigen and mRNA levels mediated by the HIV tat gene alone is not yet explained. This is the first example of human retroviruses affecting cellular gene expression in ways opposite from the action of the isolated tat gene that they encode.
It has been proposed that although both the human T-cell lymphotropic virus tat genes and the HIV tat genes activate transcription of the host genes in trans, activation by the human T-cell lymphotropic virus tat genes leads to T-cell proliferation, whereas the HIV tat gene activates genes responsible for terminal differentiation leading to cell death (39) . It is therefore necessary to determine the effects produced by the tat-III gene product on CD4 gene expression in a variety of CD4+ T-cell lines to establish whether this increase in CD4 antigen levels induced by the tat-III protein is a universal or a cell lineage-specific event and to prove a correlation with the viral cytopathic effect.
